Asia Pac ECM and Index Rebal, Shenton Research

Ke Yan, CFA, FRM

An inquisitive investment analyst with background in both finance and computing. Covering ECM research, biotech, market data analytics.

Asia Pac ECM and Index Rebal

HSI Index Earning Revision (Aug): XINYI SOLAR, Kuaishou, CK HUTCHISON, PING AN, CHINA LIFE, XIAOMI

HSI Sep 2026 Index Rebalance: Pre-Implementation Update

Hua Hong Grace (1347.HK) Q2 2026 Earnings Report Review & Full Transcript

Asia Pac IPO & Placement Research, China Biotech

Shenton Research

Shenton Research is an independent Asia Pacific equity specialist. Our quantitative research covers index rebalancing flows, alongside exchange data analytics accross Asia Pacific. On the equity capital markets side, we focus on Asia Pacific ECM, especially biotech and TMT. Our lead analyst is frequently cited by international media.

Index Rebalance

<ul>
<li>HSIL announced the Sep 2026 rebalance results, with two ADDs and no DELETE.</li>
<li>Hua Hong Grace and Weichai Power join the HSI on 7 Sep 2026.</li>
<li>Both ADDs fell into the announcement. Historically, positive opening gaps averaged -2.3% post-open, so we wait for the open before sizing.</li>
</ul>


HSIL announced the Sep 2026 rebalance results, with two ADDs and no DELETE.
Hua Hong Grace and Weichai Power join the HSI on 7 Sep 2026.
Both ADDs fell into the announcement. Historically, positive opening gaps averaged -2.3% post-open, so we wait for the open before sizing.


HSI Sep 2026 Index Rebalance: Post-Announcement Positioning

Hua Hong Semiconductor

HSI Sep 2026 Index Rebalance: Post-Announcement Positioning